| Not Yet Recruiting | Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain NCT07214974 | Noah Tech, Corp. | EARLY_Phase 1 |
| Not Yet Recruiting | Terazosin And Metabolic Energetics in Parkinson's Disease NCT07464028 | Nandakumar Narayanan | Phase 2 |
| Not Yet Recruiting | Coordinated Reset Deep Brain Stimulation for Parkinson's Disease NCT07340073 | University of Minnesota | Phase 1 |
| Not Yet Recruiting | Clinical Study of Chemogenetic Gene Therapy With AAV Virus for Parkinson's Disease Using Stereotactic Surgery NCT07533591 | Second Affiliated Hospital, School of Medicine, Zhejiang University | EARLY_Phase 1 |
| Not Yet Recruiting | Remote Haptic Rehabilitation for Parkinson's Disease NCT07457710 | Virginia Polytechnic Institute and State University | N/A |
| Not Yet Recruiting | Pilot Study of Robotic Spinal Mobilization in Parkinson's Disease NCT07376122 | Pacla Medical Limited | N/A |
| Recruiting | LFP-based Parameter Prediction in DBS for Parkinson's Disease NCT07485621 | Loes Laurijssen | — |
| Recruiting | A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early NCT07322887 | GEN İlaç ve Sağlık Ürünleri A.Ş. | Phase 2 |
| Not Yet Recruiting | Effects Of Strategy Training And PNF On Balance, Gait, And Independence In Parkinson's Disease NCT07484451 | Riphah International University | N/A |
| Recruiting | Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients NCT07455760 | Boston University Charles River Campus | N/A |
| Recruiting | Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease NCT07226284 | University of Minnesota | N/A |
| Enrolling By Invitation | Movement State-dependent Adaptive DBS for PD NCT07424508 | Doris Wang, MD, PhD | N/A |
| Not Yet Recruiting | AAV2-hAADC for Parkinson's Disease (PDCS-01) NCT07267065 | Krzysztof Bankiewicz | Phase 1 |
| Not Yet Recruiting | Understanding Alpha-Synuclein Spread in Parkinson's Disease Through Blood Biomarkers and Neuroimaging NCT07474779 | University of Pavia | N/A |
| Not Yet Recruiting | Untreated Parkinson's Disease Work-up Assessing Resident Microbiota and Duodenal Barrier Function NCT07418658 | Universitaire Ziekenhuizen KU Leuven | — |
| Recruiting | Electrophysiology-based DBS Programming for PD NCT07348705 | University of Florida | N/A |
| Recruiting | The Influence of Vibrotactile Stimulation on Self-selected Walking Speed in People With Parkinson's Disease NCT07308418 | Magnes AG | N/A |
| Recruiting | A Study of Buntanetap in Participants With PD NCT07284784 | Annovis Bio Inc. | Phase 2 / Phase 3 |
| Recruiting | Effects of the Stimulation Site of tsMS With TMS on Functional Mobility in Individuals With Parkinson's Diseas NCT07488026 | Universidade Federal de Pernambuco | N/A |
| Not Yet Recruiting | Clinical Validation of AI-powered Smart Vehicle Assisted Gait Training in Neurodegenerative Disorders NCT07230366 | Taipei Medical University Shuang Ho Hospital | N/A |
| Recruiting | Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Diseas NCT07316296 | Radboud University Medical Center | Phase 3 |
| Recruiting | Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease NCT07348250 | Invicro | EARLY_Phase 1 |
| Recruiting | LIFUS For Neurological Disorders NCT07417280 | University Health Network, Toronto | N/A |
| Not Yet Recruiting | Automated Image-Guided Programming of Deep Brain Stimulation (DBS) for Parkinson's Disease NCT07215481 | Stanford University | N/A |
| Recruiting | Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease NCT07244640 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Completed | Validity and Reliability of the Six-Minute Pegboard Ring Test in Individuals With Parkinson's Disease NCT07422064 | Sanko University | — |
| Recruiting | Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease NCT07310264 | Vertero Therapeutics | Phase 1 |
| Completed | Observational Study Evaluating Robotic Spinal Mobilization in 16 Parkinson's Disease Participants. The Study R NCT07384364 | Pacla Medical Limited | — |
| Recruiting | A Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's Disease NCT07170475 | Fujita Health University | Phase 1 |
| Not Yet Recruiting | Mindfulness-Enhanced Dual-Task Training in PD-MCI NCT06930742 | Nanjing Mingzhou Rehabilitation Hospital | N/A |
| Recruiting | Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor NCT06993571 | Universitätsklinikum Hamburg-Eppendorf | N/A |
| Recruiting | Empower Your Mind to Embrace Your Life: an Online ACT Intervention for Young-Onset Parkinson's Disease NCT07310147 | University of Coimbra | N/A |
| Recruiting | Shanghai Clinical Cohort - Parkinson's Disease (Reserve) NCT07353463 | Ruijin Hospital | — |
| Recruiting | [18F]ACI-15916 PET in α-synucleinopathies NCT06891703 | AC Immune SA | EARLY_Phase 1 |
| Recruiting | A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease NCT06773962 | TrueBinding, Inc. | Phase 2 |
| Recruiting | Pairing Subjective Patient Rating and DBS Programming NCT07336199 | Ludwig-Maximilians - University of Munich | — |
| Recruiting | IMPACT 360 for Parkinson's Disease NCT07443293 | University of British Columbia | Phase 2 |
| Recruiting | Quantification of Hsp90 in the Human Brain NCT07380204 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Recruiting | Acupuncture and Moxibustion for Motor Symptoms in Early Parkinson's Disease NCT06874803 | Jiani Wu | N/A |
| Completed | Cross-sectional Study of Vitamin B6 in Parkinson's Disease NCT07430722 | University of Rochester | — |
| Recruiting | Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants NCT06107426 | AbbVie | — |
| Recruiting | An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse E NCT05916157 | AbbVie | — |
| Withdrawn | Efficacy of Probiotics for Parkinson Disease (PD) NCT06118294 | Changhua Christian Hospital | N/A |
| Completed | Novel DBS Device in Parkinson's Disease NCT07213999 | University of Minnesota | N/A |
| Active Not Recruiting | Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of A NCT04750226 | AbbVie | Phase 3 |
| Completed | Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatmen NCT04380142 | AbbVie | Phase 3 |
| Active Not Recruiting | Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infus NCT04379050 | AbbVie | Phase 3 |
| Completed | A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD) NCT03781167 | AbbVie | Phase 3 |
| Terminated | Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic NCT03829657 | Theravance Biopharma | Phase 3 |
| Completed | Coordinated Reset Deep Brain Stimulation NCT03732898 | Boston Scientific Corporation | N/A |
| Completed | A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuo NCT03374917 | AbbVie | Phase 1 |
| Completed | COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel NCT03362879 | AbbVie | — |
| Completed | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Su NCT03033498 | AbbVie | Phase 1 |
| Completed | A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Opti NCT02799381 | AbbVie | Phase 3 |
| Recruiting | Comprehensive Assessment of Neurodegeneration and Dementia NCT03402919 | McGill University | — |
| Completed | Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy NCT02381444 | AbbVie | — |
| Completed | Establishing the Central and Peripheral Fatigue Indexes and VR Based Anti-fatigue Training Paradigm for Indivi NCT02017938 | Chang Gung University | N/A |
| Completed | Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia NCT02274766 | Adamas Pharmaceuticals, Inc. | Phase 3 |
| Completed | Open-Label Safety Study of ADS-5102 in PD Patients With LID NCT02202551 | Adamas Pharmaceuticals, Inc. | Phase 3 |
| Completed | Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy S NCT02103894 | Molecular NeuroImaging | Phase 1 |
| Completed | Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI) NCT01888185 | Milton S. Hershey Medical Center | — |
| Completed | Intranasal Glutathione in Parkinson's Disease NCT01398748 | Bastyr University | Phase 1 |
| Completed | The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics NCT02170376 | Bial - Portela C S.A. | Phase 1 |
| Completed | An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion NCT02169427 | Bial - Portela C S.A. | Phase 1 |
| Completed | Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetics NCT02169414 | Bial - Portela C S.A. | Phase 1 |
| Completed | Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin NCT02169440 | Bial - Portela C S.A. | Phase 1 |
| Completed | Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-do NCT02169466 | Bial - Portela C S.A. | Phase 1 |
| Completed | Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a S NCT02169453 | Bial - Portela C S.A. | Phase 1 |
| Completed | Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a S NCT02169479 | Bial - Portela C S.A. | Phase 1 |
| Completed | Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-do NCT02169895 | Bial - Portela C S.A. | Phase 1 |
| Completed | Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 9-1067 NCT02071810 | Bial - Portela C S.A. | Phase 1 |
| Completed | Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Benserazide NCT02778594 | Bial - Portela C S.A. | Phase 1 |
| Completed | Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and NCT02834507 | Bial - Portela C S.A. | Phase 2 |